A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.
about
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis CRetreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.Management of viral hepatitis C.Meta-analysis: combination therapy with interferon-alpha 2a/2b and ribavirin for patients with chronic hepatitis C previously non-responsive to interferon.Treatment of chronic hepatitis C: a systematic review.Role of liver biopsy in management of chronic hepatitis C: a systematic review.Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications.Successful interferon desensitization in a patient with chronic hepatitis C infection.Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.Polymorphisms of NS5B protein relates to early clearance of hepatitis C virus by interferon plus ribavirin: a pilot study.A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone.Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin.Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1.Hepatitis C virus RNA levels during initial induction or standard interferon therapy: influence of continued treatment on sustained response.Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C.Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon.Strategies in the Design of Antiviral Drugs
P2860
Q24201588-E43D2EC5-9C72-452D-97E3-CDE32B88505BQ24805127-69739E5A-7C41-4E18-B0E6-2E07C5C95C4CQ30746310-88796005-FB5A-4F6D-A342-707BEB4DEF99Q34631375-E46C661B-AACD-4C8F-8C03-99DF9DFE7D7EQ34799386-5BE868AC-0590-4975-8181-3D0F38FD143DQ34984085-4E40D086-266C-44F0-945C-371D7396B2F5Q34984098-BA5CA790-A933-4553-8774-155EF9BD5E01Q35041900-58357E14-F02F-44A3-9B26-D9D7D0653AD8Q35595630-AE3E8C1B-884C-4B87-B47B-2B349B95B72CQ36308835-39FB99B9-7CE6-4406-A92C-9D905B5E4592Q42547589-054BC001-6550-4C57-8BAA-A058687B7257Q42984535-2F5B35CC-C414-4D15-8CDB-3C08991CE191Q42984713-EB128191-632B-4C66-B33E-D04D31130AB1Q42988399-116F0316-219A-44BE-9D05-E97A4DCA9435Q43041160-170C29FA-131F-4BE3-A34A-0E18D996F315Q43047387-EB8935DB-0605-4F38-8344-F4D0F042D3A1Q43048560-2F4E31DF-1764-4BD8-8C9E-D4D03DE9EF25Q43048580-91A5DFA6-3852-4E26-B7B2-B28234B49D9CQ43049458-EF1DFCB4-7E59-4E4D-8764-DEDD68679168Q48030231-B2FC6ABB-9C0C-4813-AB69-351E4D03C6F7Q56786281-6242020C-5805-422A-9DEF-01396283F7CE
P2860
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A randomized 4-arm multicenter ...... esponding to interferon alone.
@en
A randomized 4-arm multicenter ...... esponding to interferon alone.
@nl
type
label
A randomized 4-arm multicenter ...... esponding to interferon alone.
@en
A randomized 4-arm multicenter ...... esponding to interferon alone.
@nl
prefLabel
A randomized 4-arm multicenter ...... esponding to interferon alone.
@en
A randomized 4-arm multicenter ...... esponding to interferon alone.
@nl
P2093
P356
P1433
P1476
A randomized 4-arm multicenter ...... esponding to interferon alone.
@en
P2093
A Di Napoli
C Colletta
P304
P356
10.1053/JHEP.2001.25636
P407
P577
2001-07-01T00:00:00Z